Merck

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Merck and other ETFs, options, and stocks.

About MRK

Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. 

CEO
Robert M. Davis
CEORobert M. Davis
Employees
68,000
Employees68,000
Headquarters
Kenilworth, New Jersey
HeadquartersKenilworth, New Jersey
Founded
1891
Founded1891
Employees
68,000
Employees68,000

MRK Key Statistics

Market cap
220.34B
Market cap220.34B
Price-Earnings ratio
13.28
Price-Earnings ratio13.28
Dividend yield
3.13
Dividend yield3.13
Average volume
8.54M
Average volume8.54M
High today
$87.61
High today$87.61
Low today
$86.26
Low today$86.26
Open price
$86.90
Open price$86.90
Volume
2.13M
Volume2.13M
52 Week high
$95.72
52 Week high$95.72
52 Week low
$71.50
52 Week low$71.50

MRK News

Benzinga 1d
Merck Inks Supply Deal With Sinopharm To Commercialize COVID-19 Pills In China

Merck & Co Inc (NYSE: MRK) signed a cooperation framework agreement in China for its COVID-19 antiviral pills, which were co-developed by Ridgeback Therapeutics...

Merck Inks Supply Deal With Sinopharm To Commercialize COVID-19 Pills In China
Reuters 2d
Merck agrees to allow Sinopharm to sell molnupiravir COVID drug in China - Reuters

NEW YORK, Sept 28 (Reuters) - Drugmaker Merck & Co (MRK.N) said on Wednesday that it agreed to allow China's Sinopharm (1099.HK) to distribute and...

Merck agrees to allow Sinopharm to sell molnupiravir COVID drug in China - Reuters
Simply Wall St 2d
With 75% ownership, Merck & Co., Inc. boasts of strong institutional backing

If you want to know who really controls Merck & Co., Inc. (NYSE:MRK), then you'll have to look at the makeup of its share registry. With 75% stake, institutions...

With 75% ownership, Merck & Co., Inc. boasts of strong institutional backing

Analyst ratings

56%

of 25 ratings
Buy
56%
Hold
44%
Sell
0%

MRK Earnings

$0.00
$0.71
$1.43
$2.14
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Available Oct 27, Pre-Market
ActualAvailable Oct 27, Pre-Market

More MRK News

Simply Wall St 2d
We Ran A Stock Scan For Earnings Growth And Merck Passed With Ease

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even companies that have no revenue, no profit, an...

We Ran A Stock Scan For Earnings Growth And Merck Passed With Ease
Simply Wall St 6d
Merck shareholders have earned a 11% CAGR over the last five years

If you buy and hold a stock for many years, you'd hope to be making a profit. Better yet, you'd like to see the share price move up more than the market average...

Merck shareholders have earned a 11% CAGR over the last five years
Investor's Business Daily 7d
With Seagen News Lacking, Is Merck Stock A Buy Or A Sell?

Merck stock jumped in September after winning a patent battle against Viatris (VTRS) and snagging approval in China for an AstraZeneca-partnered ovarian cancer...

With Seagen News Lacking, Is Merck Stock A Buy Or A Sell?
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.